12:00 AM
 | 
May 20, 2013
 |  BC Week In Review  |  Company News  |  Other News

Mercachem B.V., ProQinase cancer news

CROs ProQinase and Mercachem received a €2.5 million ($3.3 million) grant from the EU's Eurostars program to...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >